Freshpaint vs Segment
An independent, review-free comparison compiled by the SaaSTracker editorial team. Both products are profiled in full, and neither can pay for placement here.
The short answer
Both sides assessedFreshpaint compared with Segment
Segment has the larger destination catalogue, the industry-standard API, and stronger governance tooling, and it is the default choice for general commercial use. Freshpaint wins decisively in healthcare, where it will sign a business associate agreement and actively block protected health information from reaching third parties, which Segment does not position itself to do. Outside that context, Segment is usually the safer general-purpose pick.
Segment compared with Freshpaint
Freshpaint exists for the two things Segment deliberately does not do: capture events without instrumenting them first, and stop protected health information reaching a third-party pixel under a signed business associate agreement. Segment expects a tracking plan and an owner for it, and is cheaper to start with, free to around 1,000 monthly tracked users against Freshpaint's quoted commercial pricing. Healthcare marketing teams and teams with no engineering queue choose Freshpaint; teams with governed instrumentation and a long destination list stay on Segment.
Choose Freshpaint if
Healthcare organizations that must run digital marketing without leaking protected health information to analytics and ad platforms, and marketing teams anywhere that want event tracking without an engineering dependency.
Choose Segment if
Companies with several downstream tools and enough engineering discipline to maintain a tracking plan, who want one instrumentation to serve analytics, marketing, support, and the warehouse at once.
Side by side
13 attributes| Attribute | Freshpaint | Segment |
|---|---|---|
| Category | CDP | CDP |
| Starting price | Quoted; commercial plans typically start in the hundreds of dollars per month with healthcare deployments priced higher (free trial) | Free for up to around 1,000 monthly tracked users; Team plans from roughly $120 per month (free plan available) |
| Pricing model | Quoted subscription based on volume, destinations, and compliance requirements. Healthcare deployments including business associate agreements and PHI controls are priced above general commercial use. | Tiered subscription driven by monthly tracked users on lower plans and by volume and features at scale, with a free developer tier. Protocols and Unify are generally licensed above the base plan, and enterprise agreements are quoted annually. |
| Free plan | No | Around 1,000 monthly tracked users with core connections and a limited destination count |
| Free trial | Trial and pilot arrangements available through sales | Free plan plus trial access to paid capabilities |
| Best for | Healthcare organizations that must run digital marketing without leaking protected health information to analytics and ad platforms, and marketing teams anywhere that want event tracking without an engineering dependency. | Companies with several downstream tools and enough engineering discipline to maintain a tracking plan, who want one instrumentation to serve analytics, marketing, support, and the warehouse at once. |
| Setup time | Basic installation is quick, but healthcare deployments include an audit of every existing pixel and data flow, which typically takes several weeks and is the substantive part of the work. | A basic install is a day. A responsible implementation, agreeing a tracking plan, naming events consistently, mapping destinations, and validating in a development source, typically takes two to six weeks depending on how many surfaces are involved. |
| Learning curve | Low for defining events, higher for governance. Teams must decide which properties may leave the platform, and in regulated contexts that decision belongs to compliance rather than marketing. | Moderate for engineers, higher for the organization. The tool is simple; agreeing what an event means across marketing, product, and finance is the hard part and is not a technical problem. |
| Platforms | Web (JavaScript), Mobile SDKs, Server-side libraries, Google Tag Manager | JavaScript (analytics.js), iOS, Android, React Native, Server libraries across major languages, HTTP tracking API |
| Compliance | HIPAA (with BAA), GDPR, CCPA, SOC 2 Type II | GDPR, CCPA, SOC 2 Type II, ISO 27001, HIPAA support on qualifying plans |
| Founded | 2018 | 2011 |
| Headquarters | Denver, Colorado, United States | San Francisco, California, United States |
| Ownership | Private, venture-backed | Acquired by Twilio (2020) |
Strengths and limitations
Freshpaint
Strengths
- Autotracking removes the engineering bottleneck that blocks most analytics work.
- Retroactive event definition means historical data is available for questions asked later.
- The clearest answer available for healthcare marketers who must measure without leaking protected health information.
- Willingness to sign business associate agreements, which most analytics and ad vendors refuse.
Limitations
- No published pricing or self-serve entry, so evaluation requires a sales process.
- Autotracking can produce noisy data without governance discipline, since capturing everything is not the same as defining anything.
- Narrower destination catalogue than the largest general-purpose CDPs.
- Analysis happens elsewhere; the product routes and governs rather than reporting.
Segment
Strengths
- Defined the category and its API is the industry standard, so documentation, hiring, and portability all favor it.
- The largest destination catalogue by a wide margin, including long-tail tools competitors do not support.
- Replay of historical events into new destinations is a genuinely differentiating capability.
- Protocols governance addresses the real cause of bad analytics, which is schema drift rather than missing tools.
Limitations
- Costly at scale, with monthly tracked user pricing that rises faster than most buyers expect.
- The most valuable features, governance and profiles, sit above the self-serve tiers.
- It moves data but does nothing with it, so value depends entirely on the tools downstream.
- Requires ongoing schema ownership; without it a CDP distributes bad data more efficiently.
Pricing compared
Freshpaint
Quoted subscription based on volume, destinations, and compliance requirements. Healthcare deployments including business associate agreements and PHI controls are priced above general commercial use.
- CommercialQuoted
- HealthcareQuoted
- EnterpriseQuoted
In healthcare the value calculation is unusual: the alternative to Freshpaint is often not another CDP but turning off measurement entirely, or accepting regulatory exposure that has already produced substantial settlements elsewhere in the sector. Against that, the price is easy to justify. Outside healthcare it is a competent autotracking CDP whose main draw is removing the engineering dependency, competing against cheaper and more established general-purpose platforms where the specialization adds no value.
Segment
Tiered subscription driven by monthly tracked users on lower plans and by volume and features at scale, with a free developer tier. Protocols and Unify are generally licensed above the base plan, and enterprise agreements are quoted annually.
- Free$0
- TeamFrom about $120
- BusinessQuoted
Segment is expensive and worth it in a specific situation: several downstream tools, real engineering cost in maintaining instrumentation, and enough data discipline to use governance features. In that case it saves more engineering time than it costs and prevents the data-quality decay that quietly ruins analytics. Outside it, cheaper alternatives, RudderStack, Jitsu, or simply the warehouse plus a reverse ETL tool, deliver most of the routing benefit for a fraction of the price, which is why so many companies leave once volume makes the invoice visible.
Editorial verdict on each
Freshpaint
Freshpaint has done something unusual for a customer data platform: found a market where the alternative is not a competing vendor but switching measurement off entirely. Healthcare marketers facing regulatory exposure over tracking pixels have very few credible options, and a CDP that inspects outbound flows, blocks protected health information, signs a business associate agreement, and produces an audit trail is worth considerably more than its feature list suggests. Outside that context it is a solid autotracking CDP whose main virtue is independence from the engineering queue, competing against cheaper and broader general-purpose platforms. Buy it for the compliance problem it was rebuilt to solve, and compare it on ordinary CDP terms only if you do not have that problem.
Read the full Freshpaint profileSegment
Segment created this category and still defines it, and its API remaining the industry's shared vocabulary is a real, durable advantage: instrumentation written against it is portable, well documented, and understood by anyone you hire. The destination catalogue, replay capability, and governance tooling are best in class, and for a company running many downstream tools the engineering time saved genuinely exceeds the cost. The pressure is entirely on price. Monthly tracked user pricing escalates faster than buyers plan for, the features that justify a CDP sit above the self-serve tiers, and API-compatible competitors have made leaving unusually easy. Adopt it deliberately, own the tracking plan from day one, and model the bill at three times your current traffic before signing.
Read the full Segment profileFreshpaint profile last reviewed 2026-08-22; Segment last reviewed 2026-08-22. Pricing is compiled from public sources and can change without notice. See our methodology.